Uric acid nephrolithiasis: An update

被引:26
|
作者
Cicerello, Elisa [1 ]
机构
[1] Osped Ca Foncello, Unita Complessa Urol, Piazzale Osped, I-31100 Treviso, Italy
关键词
Uric acid stones; urinary pH; alkalization; gout; allopurinol; febuxostat;
D O I
10.1177/0391560318766823
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Uric acid nephrolithiasis appears to increase in prevalence. While a relationship between uric acid stones and low urinary pH has been for long known, additional association with various metabolic conditions and pathophysiological basis has recently been elucidated. Some conditions such as diabetes and metabolic syndrome disease, excessive dietary intake, and increased endogenous uric acid production and/or defect in ammoniagenesis are associated with low urinary pH. In addition, the phenomenon of global warming could result in an increase in areas with greater climate risk for uric acid stone formation. There are three therapeutic steps to be taken for management of uric acid stones: identification of urinary pH profiles, assessment of urinary volume status, and identification of disorders leading to excessive uric acid production. However, the most important factor for uric acid stone formation is acid urinary pH, which is a prerequisite for uric acid precipitation. This article reviews recent insights into the pathophysiology of uric acid stones and their management.
引用
下载
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [21] Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
    Sakhaee, K
    Adams-Huet, B
    Moe, OW
    Pak, CYC
    KIDNEY INTERNATIONAL, 2002, 62 (03) : 971 - 979
  • [22] Novel insights into the pathogenesis of uric acid nephrolithiasis
    Maalouf, NM
    Cameron, MA
    Moe, OW
    Sakhaee, K
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (02): : 181 - 189
  • [23] Uric acid nephrolithiasis: Current concepts and controversies
    Shekarriz, B
    Stoller, ML
    JOURNAL OF UROLOGY, 2002, 168 (04): : 1307 - 1314
  • [24] URIC-ACID SATURATION IN CALCIUM NEPHROLITHIASIS
    COE, FL
    STRAUSS, AL
    TEMBE, V
    DUN, SL
    KIDNEY INTERNATIONAL, 1980, 17 (05) : 662 - 668
  • [25] PREVENTION OF RECURRENCES IN URIC-ACID NEPHROLITHIASIS
    WESOLOWSKI, S
    MILEWSKI, JB
    CIESLAK, A
    NARTELULKOWSKA, N
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 1978, 10 (01) : 3 - 6
  • [26] Theobromine Inhibits Uric Acid Crystallization. A Potential Application in the Treatment of Uric Acid Nephrolithiasis
    Grases, Felix
    Rodriguez, Adrian
    Costa-Bauza, Antonia
    PLOS ONE, 2014, 9 (10):
  • [27] The efficacy of medical dissolution therapy for uric acid nephrolithiasis
    Tonyali, Senol
    WORLD JOURNAL OF UROLOGY, 2020, 38 (11) : 2999 - 2999
  • [28] URIC-ACID AND CALCIUM-OXALATE NEPHROLITHIASIS
    COE, FL
    KASSIRER, JP
    SHIELDS, M
    COHEN, JJ
    BUSHINSKY, D
    ZITMAN, I
    SOBEL, G
    MICHEL, S
    LANGMAN, C
    KIDNEY INTERNATIONAL, 1983, 24 (03) : 392 - 403
  • [29] Medical dissolution therapy for the treatment of uric acid nephrolithiasis
    Gridley, Chad M.
    Sourial, Michael W.
    Lehman, Amy
    Knudsen, Bodo E.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (11) : 2509 - 2515
  • [30] Correlation between the metabolic syndrome and uric acid nephrolithiasis
    Seo, Youngun
    Heo, Jeongmoon
    Sim, Kisik
    Park, Jayoung
    JOURNAL OF ENDOUROLOGY, 2007, 21 : A52 - A52